Exploring Bayesian Design In Phase I Oncology Trials
Exploring Bayesian Design In Phase I Oncology Trials reveals several interesting facts.
- Historically,
- The 2014 East User Group Meeting's invited speaker presentations: Satrajit Roychoudhury, from Novartis, reveals lessons ...
- This talk covers several ways to make
- ...
- Yannis Jeimiai, Vice President, Cytel Beginning with an overview of applicable adaptive approaches and the current regulatory ...
In-Depth Information on Bayesian Design In Phase I Oncology Trials
Phase I oncology clinical trials Ying Lu Stanford University, USA. Tianyu Li and Nabihah Tayob, Wendy London, PhD, is Associate Professor, Harvard Medical School and Director of Biostatistics, Boston Children's Hospital.
Suyu Liu, PhD is Associate Professor, Department of Biostatistics at The University of Texas MD Anderson
Stay tuned for more updates related to Bayesian Design In Phase I Oncology Trials.